PharmiWeb

AIML Subsidiary NeuralCloud Solutions Engages Lonacas Consultants to Lead Regulatory Submission for CardioYield(TM) in Jamaica

Enabled ECG Diagnostics to Address the Growing Cardiovascular Disease Burden in Jamaica TORONTO, ON / ACCESS Newswire / November 4, 2025 / AI/ML Innovations Inc. ("AIML" or the "Company") ...
PharmiWeb

Coalition for Patient Rights Announces Update on Their Inaugural Hoedown Nov. 15; Lead-Up Performance by Country Artist Jonny Hazard at Downtown Container Park Nov. 5

Toy drive with Operation Warm Heart benefits Airmen at Nellis & Creech AFBs; Family fun, food, spirits and beverages made affordable and accessible by the Compassion Center; Sponsors urged to confirm ...
PharmiWeb

Research by top universities together with Oncopeptides on NK cell engagers to be presented at ASH

Stockholm – November 3, 2025 – Oncopeptides AB (publ) (Nasdaq Stockholm: ONCO), a biotech company focused on difficult-to-treat cancers, today announces that a collaborative study within the Eurostars ...
PharmiWeb

Insulet Champions Workplace Inclusion for People with Diabetes with New Data and Tools Released for Diabetes Awareness Month

Insulet launches campaign inspired by the International Diabetes Federation’s focus on diabetes, well-being, and the workplace“The Day Diabetes Showed Up to Work” campaign recognizes the unique needs ...
PharmiWeb

University of Huddersfield Pharmacist honoured at Science and Technology Premier Awards 2025 for research to bring clean drinking water to parts of Pakistan

November 2025​University of Huddersfield Pharmacist Dr Muhammad Usman Ghori has been honoured at the Science and Technology Premier Awards 2025 for his research to bring clean, affordable drinking ...
PharmiWeb

UK-first metrology biofoundry facility opened at the National Physical Laboratory (NPL)

Lord Vallance, Minister for Science, Innovation, Research and Nuclear opens new facility which will support the acceleration of UK engineering biology innovationLondon, 3 November 2025 - The National ...
PharmiWeb

U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

KYGEVVI® (doxecitine and doxribtimine) powder for oral solution (2g/2g) is approved for the treatment of thymidine kinase 2 deficiency (TK2d) in adults and pediatric patients with an age of symptom ...
PharmiWeb

Equitech-Bio Extends Global Reach With Bioz Badges, Showcasing Citation Engagement From Researchers

PALO ALTO, CA / ACCESS Newswire / November 4, 2025 / Bioz, Inc., the leader in turning scientific literature into actionable product validation, is proud to announce its collaboration with ...
PharmiWeb

Tulyp Medical emerges from Sofinnova’s medtech accelerator and announces FDA submission following initial first-in-human use

Company unveils patented technology designed to help maintain healthy blood flow during vascular proceduresBacked by Sofinnova MD Start and led by experienced medtech entrepreneurs and ...
PharmiWeb

Independent Expert Consensus Confirms Clinical Relevance of CTCs and Identifies Parsortix Platform as Leading Next-Generation Technology

Expert consensus predicts integration of CTC testing into routine clinical practice within 5 years  2.    CTCs provide distinct and impactful information that is not captured by circulating tumour DNA ...
PharmiWeb

CNX Therapeutics acquires Sativex® global business from Jazz Pharmaceuticals

CNX Therapeutics acquires the global Sativex business from Jazz Pharmaceuticals to bolster its CNS specialty medicines platform while Jazz rebalances its portfolio toward core areas.
PharmiWeb

NAYA Therapeutics to Present at the Network for Optimized Astatine-Labeled Radiopharmaceuticals (NOAR) Europe Annual Meeting

MIAMI, FL / ACCESS Newswire / November 4, 2025 / NAYA Therapeutics, a clinical-stage biopharmaceutical company dedicated to pioneering the next generation of cancer therapies through the development ...